http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100467312-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-06 |
| filingDate | 2001-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100467312-B1 |
| titleOfInvention | Antiviral isoxazoline and isoxazole nucleosides and method of their manufacture |
| abstract | The present invention provides an isooxazolin (Formula 1) or isoxazole (Formula 2) having excellent antiviral efficacy having the formula:n n n n n n n n n n Wherein R is hydrogen or an alkyl group of C1-C5, R 'is a hydrogen, alkyl or aryl group of C1-C10, X and Y are hydrogen or a protecting group;n n n n n n n n n n Wherein R is hydrogen, a halogen element, or an alkyl group of C1-C5, R 'is hydrogen, an alkyl or aryl group of C1-C10, and X and Y are hydrogen or a protecting group. |
| priorityDate | 2001-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 931.